Literature DB >> 17086988

[Activation of RHOA gene transcription in epithelial tumors may be caused by gene amplification and/or demethylation of its promotor region].

E A Braga, V I Loginov, E A Klimov, G Kilosanidze, D S Khodyrev, N L Kaganova, T P Kazybskaia, V D Ermilova, R F Gar'kavtseva, I V Pronina, O I Rud'ko, E R Zabarskiĭ, G E Sulimova, L L Kiselev.   

Abstract

RHOA protein, a member of small GTPases family, is implicated in cell morphogenesis, adhesion, and in cell cycle regulation. RHOA gene (3p21.31) exhibits cell transformation activity, and therefore gene is considered as a potential oncogene. The aim of this study was to investigate RHOA transcription and copy number changes in three epithelial tumors (breast, renal cell and epithelial ovarian carcinomas, 45 tumor/normal pairs altogether). EII, HhaI, AciI n Bsh1236I). Hypomethylation of the RHOA promoter region in tumor DNA was observed two times more frequently than increased methylation. Moreover, all (15) cancer cases with hypomethylation of the RHOA gene showed a 2-10 fold increased expression of RHOA. It was concluded that gene copy multiplication and demethylation of the RHOA promoter region can contribute to transcription activation of this gene in epithelial tumors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17086988

Source DB:  PubMed          Journal:  Mol Biol (Mosk)        ISSN: 0026-8984


  2 in total

1.  Decitabine impact on the endocytosis regulator RhoA, the folate carriers RFC1 and FOLR1, and the glucose transporter GLUT4 in human tumors.

Authors:  Jean-Pierre Issa; Ignacio I Wistuba; Razelle Kurzrock; David J Stewart; Maria I Nunez; Jaroslav Jelinek; David Hong; Sanjay Gupta
Journal:  Clin Epigenetics       Date:  2014-01-09       Impact factor: 6.551

2.  Effects of calcium channel on ovarian cancer cells.

Authors:  Chunyun Zhang; Hailing Li
Journal:  Oncol Lett       Date:  2017-09-26       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.